Artritis reactivas

EMC - Aparato Locomotor - Tập 42 - Trang 1-10 - 2009
C. Hacquard-Bouder1,2,3, M. Breban1,2,3
1Service de rhumatologie, Hôpital Ambroise Paré, 9, avenue Charles-de-Gaulle, 92100 Boulogne-Billancourt, France
2Université de Versailles–Saint-Quentin-en-Yvelines, 55, avenue de Paris, 78035 Versailles cedex, France
3Institut Cochin, INSERM U567, CNRS UMR 8104, IFR116, 27, rue du faubourg Saint-Jacques, 75014 Paris, France

Tài liệu tham khảo

Hill Gaston, 2003, Arthritis associated with enteric infection, Best Pract Res Clin Rheumatol, 17, 219, 10.1016/S1521-6942(02)00104-3 Aho, 1973, HL-A antigen 27 and reactive arthritis, Lancet, 2, 157, 10.1016/S0140-6736(73)93109-7 Leirisalo-Repo, 2005, Reactive arthritis, Scand. J. Rheumatol., 34, 251, 10.1080/03009740500202540 Kvien, 1994, Reactive arthritis: incidence, triggering agents and clinical presentation, J. Rheumatol., 21, 115 Toivanen, 2004, Reactive arthritis, Best Pract Res Clin Rheumatol, 18, 689, 10.1016/j.berh.2004.05.008 Hannu, 2005, Reactive arthritis attributable to Shigella infection: a clinical and epidemiological nationwide study, Ann. Rheum. Dis., 64, 594, 10.1136/ard.2004.027524 Zeidler, 2004, Chlamydia-induced arthritis, Curr. Opin. Rheumatol., 16, 380, 10.1097/01.bor.0000126150.04251.f9 Sieper, 1999, Problems and advances in the diagnosis of reactive arthritis, J. Rheumatol., 26, 1222 Pacheco-Tena, 1999, A proposal for the classification of patients for clinical and experimental studies on reactive arthritis, J. Rheumatol., 26, 1338 Inman, 1999, Classification criteria for reactive arthritis, J. Rheumatol., 26, 1219 Willkens, 1981, Reiter's syndrome. Evaluation of preliminary criteria for definite disease, Arthritis Rheum., 24, 844, 10.1002/art.1780240612 Amor, 1998, Reiter's syndrome. Diagnosis and clinical features, Rheum. Dis. Clin. North Am., 24, 677, 10.1016/S0889-857X(05)70037-5 Keat, 1983, Reiter's syndrome and reactive arthritis in perspective, N. Engl. J. Med., 309, 1606, 10.1056/NEJM198312293092604 Collantes, 2007, Disease pattern of spondyloarthropathies in Spain: description of the first national registry (REGISPONSER) extended report, Rheumatol., 46, 1309, 10.1093/rheumatology/kem084 Rosenbaum, 1989, Characterization of uveitis associated with spondyloarthritis, J. Rheumatol., 16, 792 De Vos, 1989, Ileocolonoscopy in seronegative spondylarthropathy, Gastroenterology, 96, 339, 10.1016/0016-5085(89)91557-6 Mielants, 1996, Course of gut inflammation in spondylarthropathies and therapeutic consequences, Baillieres Clin. Rheumatol., 10, 147, 10.1016/S0950-3579(96)80010-0 Franks, 2004, Psoriatic arthritis and Reiter syndrome Calin, 1979, Keratodermia blennorrhagica and mucocutaneous manifestations of Reiter's syndrome, Ann. Rheum. Dis., 38, 68, 10.1136/ard.38.Suppl_1.68 Fisk, 1982, Reiter's disease, BMJ, 284, 3, 10.1136/bmj.284.6308.3 Deer, 1991, Cardiac conduction manifestations of Reiter's syndrome, South. Med. J., 84, 799, 10.1097/00007611-199106000-00035 Neu, 1960, Cardiac involvement in Reiter's disease: report of a case with review of the literature, Ann. Intern. Med., 53, 215, 10.7326/0003-4819-53-1-215 Paulus, 1972, Aortic insufficiency in five patients with Reiter's syndrome. A detailed clinical and pathologic study, Am. J. Med., 53, 464, 10.1016/0002-9343(72)90142-8 Sieper, 2002, Diagnosing reactive arthritis: role of clinical setting in the value of serologic and microbiologic assays, Arthritis Rheum., 46, 319, 10.1002/art.504 Mannoja, 2005, Lumbosacral radiographic signs in patients with previous enteroarthritis or uroarthritis, Ann. Rheum. Dis., 64, 936, 10.1136/ard.2004.027086 D'Agostino, 2003, Assessment of peripheral enthesitis in the spondylarthropathies by ultrasonography combined with power doppler: a cross-sectional study, Arthritis Rheum., 48, 523, 10.1002/art.10812 McGonagle, 1999, Enthesitis in spondyloarthropathy, Curr. Opin. Rheumatol., 11, 244, 10.1097/00002281-199907000-00004 Weyand, 1989, Immune responses to Borrelia burgdorferi in patients with reactive arthritis, Arthritis Rheum., 32, 1057, 10.1002/anr.1780320902 Rawlins, 2005, Evaluation of a western blot method for the detection of Yersinia antibodies: evidence of serological cross-reactivity between Yersinia outer membrane proteins and Borrelia burgdorferi, Clin. Diagn. Lab. Immunol., 12, 1269 Khan, 1982, Axial arthropathy in Whipple's disease, J. Rheumatol., 9, 928 Hannequin, 1989, Axial arthropathy in a case of Whipple's disease, Rev. Rhum. Mal. Osteoartic., 56, 781 Dobbins, 1987, HLA antigens in Whipple's disease, Arthritis Rheum., 30, 102, 10.1002/art.1780300115 Tinazzi, 2006, Reactive arthritis following BCG immunotherapy for urinary bladder carcinoma: a systematic review, Rheumatol. Int., 26, 481, 10.1007/s00296-005-0059-2 Hogan, 2004, Chlamydial persistence: beyond the biphasic paradigm, Infect. Immun., 72, 1843, 10.1128/IAI.72.4.1843-1855.2004 Kuipers, 2003, How does Chlamydia cause arthritis?, Rheum. Dis. Clin. North Am., 29, 613, 10.1016/S0889-857X(03)00027-9 Cox, 2003, Investigation of infectious agents associated with arthritis by reverse transcription PCR of bacterial rRNA, Arthritis Res. Ther., 5, 10.1186/ar602 Gerard, 1998, Synovial Chlamydia trachomatis in patients with reactive arthritis/Reiter's syndrome are viable but show aberrant gene expression, J. Rheumatol., 25, 734 Granfors, 1998, Persistence of Yersinia antigens in peripheral blood cells from patients with Yersinia enterocolitica O:3 infection with or without reactive arthritis, Arthritis Rheum., 41, 855, 10.1002/1529-0131(199805)41:5<855::AID-ART12>3.0.CO;2-J Clements, 2002, Polynucleotide phosphorylase is a global regulator of virulence and persistency in Salmonella Enterica, Proc. Natl. Acad. Sci. USA, 99, 8784, 10.1073/pnas.132047099 Da Costa, 2004, Heat shock protein 60 from Chlamydia pneumoniae elicits an unusual set of inflammatory responses via Toll-like receptor 2 and 4 in vivo, Eur. J. Immunol., 34, 2874, 10.1002/eji.200425101 Astrauskiene, 2007, New insights into bacterial persistence in reactive arthritis, Clin. Exp. Rheumatol., 25, 470 Thomson, 1994, Secretory immune response and clinical sequelae of Salmonella infection in a point source cohort, J. Rheumatol., 21, 132 Sprenkels, 1995, Spondylarthropathy and selective IgA deficiency, Rheumatol. Int., 14, 261, 10.1007/BF00262094 Mertz, 1998, Characterization of the synovial T cell response to various recombinant Yersinia antigens in Yersinia enterocolitica-triggered reactive arthritis, Arthritis Rheum., 41, 315, 10.1002/1529-0131(199802)41:2<315::AID-ART16>3.0.CO;2-# Gaston, 1996, Identification of 2 Chlamydia trachomatis antigens recognized by synovial fluid T cells from patients with Chlamydia induced reactive arthritis, J. Rheumatol., 23, 130 Matyszak, 2002, Uptake and processing of Chlamydia trachomatis by human dendritic cells, Eur. J. Immunol., 32, 742, 10.1002/1521-4141(200203)32:3<742::AID-IMMU742>3.0.CO;2-9 Stagg, 1996, Antigen-presenting cells but not lymphocytes in the joints may indicate the cause of reactive arthritis, Br. J. Rheumatol., 35, 1082, 10.1093/rheumatology/35.11.1082 Baeten, 2002, Macrophages expressing the scavenger receptor CD163: a link between immune alterations of the gut and synovial inflammation in spondyloarthropathy, J. Pathol., 196, 343, 10.1002/path.1044 Baeten, 2004, The histopathology of spondyloarthropathy, Curr. Mol. Med., 4, 1, 10.2174/1566524043479310 Ekman, 2000, Modification of disease outcome in Salmonella-infected patients by HLA-B27, Arthritis Rheum., 43, 1527, 10.1002/1529-0131(200007)43:7<1527::AID-ANR17>3.0.CO;2-G Huppertz, 1997, Invasion and persistence of Salmonella in human fibroblasts positive or negative for endogenous HLA B27, Ann. Rheum. Dis., 56, 671, 10.1136/ard.56.11.671 Liu, 2001, Insights into the role of infection in the spondyloarthropathies, Curr. Rheumatol. Rep., 3, 428, 10.1007/s11926-996-0014-6 Young, 2001, HLA-B27 expression does not modulate intracellular Chlamydia trachomatis infection of cell lines, Infect. Immun., 69, 6670, 10.1128/IAI.69.11.6670-6675.2001 Saarinen, 2002, Invasion of Salmonella into human intestinal epithelial cells is modulated by HLA-B27, Rheumatol., 41, 651, 10.1093/rheumatology/41.6.651 Taurog, 1993, Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of expression of B27, J. Immunol., 150, 4168, 10.4049/jimmunol.150.9.4168 Cauli, 2002, Increased level of HLA-B27 expression in ankylosing spondylitis patients compared with healthy HLA-B27-positive subjects: a possible further susceptibility factor for the development of disease, Rheumatol., 41, 1375, 10.1093/rheumatology/41.12.1375 Taurog, 1993, Effect of the germfree state on the inflammatory disease of HLA-B27 transgenic rats: a split result, Arthritis Rheum., 36, S46 Benjamin, 1990, Guilt by association: HLA-B27 and ankylosing spondylitis, Immunol. Today, 11, 137, 10.1016/0167-5699(90)90051-A Hermann, 1993, HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis, Lancet, 342, 646, 10.1016/0140-6736(93)91760-J Ugrinovic, 1997, A single nonamer from the Yersinia 60-kDa heat shock protein is the target of HLA-B27-restricted CTL response in Yersinia-induced reactive arthritis, J. Immunol., 159, 5715, 10.4049/jimmunol.159.11.5715 Kuon, 2001, Identification of HLA-B27-restricted peptides from the Chlamydia trachomatis proteome with possible relevance to HLA-B27-associated diseases, J. Immunol., 167, 4738, 10.4049/jimmunol.167.8.4738 Falgarone, 1999, The cytotoxic T cell-mediated response against Yersinia pseudotuberculosis in HLA-B27 transgenic rat, Infect. Immun., 67, 3773, 10.1128/IAI.67.8.3773-3779.1999 Falgarone, 1999, Coordinate involvement of invasin and Yop proteins in a Yersinia psudotuberculosis-specific class I-restricted cytotoxic T cell-mediated response, J. Immunol., 162, 2875, 10.4049/jimmunol.162.5.2875 Antoniou, 2004, Formation of HLA-B27 homodimers and their relationship to assembly kinetics, J. Biol. Chem., 279, 8895, 10.1074/jbc.M311757200 Turner, 2005, HLA-B27 misfolding in transgenic rats is associated with activation of the unfolded protein response, J. Immunol., 175, 2438, 10.4049/jimmunol.175.4.2438 Hacquard-Bouder, 2004, Defective costimulatory function is a striking feature of antigen-presenting cells in an HLA-B27-transgenic rat model of spondylarthropathy, Arthritis Rheum., 50, 1624, 10.1002/art.20211 Hacquard-Bouder, 2007, Alteration of antigen-independent immunologic synapse formation between dendritic cells from HLA-B27-transgenic rats and CD4+ T cells: selective impairment of costimulatory molecule engagement by mature HLA-B27, Arthritis Rheum., 56, 1478, 10.1002/art.22572 Leirisalo, 1982, Follow-up study on patients with Reiter's disease and reactive arthritis, with special reference to HLA-B27, Arthritis Rheum., 25, 249, 10.1002/art.1780250302 Leirisalo-Repo, 1988, Ten-year follow-up study of patients with Yersinia arthritis, Arthritis Rheum., 31, 533, 10.1002/art.1780310410 Yli-Kerttula, 1995, Ten-year follow-up study of patients from a Yersinia pseudotuberculosis III outbreak, Clin. Exp. Rheumatol., 13, 333 Hannu, 2006, Reactive arthritis or post-infectious arthritis?, Best Pract Res Clin Rheumatol, 20, 419, 10.1016/j.berh.2006.02.003 Thomson, 1995, Post-Salmonella reactive arthritis: late clinical sequelae in a point source cohort, Am. J. Med., 98, 13, 10.1016/S0002-9343(99)80076-X Leirisalo-Repo, 1997, Long-term prognosis of reactive Salmonella arthritis, Ann. Rheum. Dis., 56, 516, 10.1136/ard.56.9.516 Sairanen, 1969, Reiter's syndrome: a follow-up study, Acta Med. Scand., 185, 57, 10.1111/j.0954-6820.1969.tb07298.x Pope, 2007, Campylobacter reactive arthritis: a systematic review, Semin. Arthritis Rheum., 37, 48, 10.1016/j.semarthrit.2006.12.006 Locht, 2002, Comparison of rheumatological and gastrointestinal symptoms after infection with Campylobacter jejuni/coli and enterotoxigenic Escherichia coli, Ann. Rheum. Dis., 61, 448, 10.1136/ard.61.5.448 Bremell, 1991, Rheumatic symptoms following an outbreak of Campylobacter enteritis: a five year follow-up, Ann. Rheum. Dis., 50, 934, 10.1136/ard.50.12.934 Sieper, 1999, No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis: a three-month, multicenter, double-blind, randomized, placebo-controlled study, Arthritis Rheum., 42, 1386, 10.1002/1529-0131(199907)42:7<1386::AID-ANR12>3.0.CO;2-E Yli-Kerttula, 2000, Effect of a three month course of ciprofloxacin on the outcome of reactive arthritis, Ann. Rheum. Dis., 59, 565, 10.1136/ard.59.7.565 Laasila, 2003, Antibiotic treatment and long term prognosis of reactive arthritis, Ann. Rheum. Dis., 62, 655, 10.1136/ard.62.7.655 Putschky, 2006, Comparing 10-day and 4-month doxycycline courses for treatment of Chlamydia trachomatis-reactive arthritis: a prospective, double-blind trial, Ann. Rheum. Dis., 65, 1521, 10.1136/ard.2005.045484 Chen, 2005, Sulfasalazine for ankylosing spondylitis, Cochrane Database Syst. Rev., 10.1002/14651858.CD004800.pub2 Clegg, 1996, Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter's syndrome). A Department of Veterans Affairs Cooperative Study, Arthritis Rheum., 39, 2021, 10.1002/art.1780391211 Meador, 2002, TNF involvement and anti-TNF therapy of reactive and unclassified arthritis, Clin. Exp. Rheumatol., 20 Oili, 2003, Treatment of reactive arthritis with infliximab, Scand. J. Rheumatol., 32, 122, 10.1080/03009740310000157 Braun, 2006, First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis, Ann. Rheum. Dis., 65, 316, 10.1136/ard.2005.040758